Sign in

CIK 0000200406

  • Large accelerated filer

JOHNSON & JOHNSON

Sign in to watch
Ticker
JNJ
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Jan 3
Incorporated
NJ
Entity type
Operating
EIN
221024240
Phone
+1 732-524-2455
Business address
ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
Former names
JOHNSON & JOHNSON ET AL
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$12,947,986
in 2 filings

Net −$12,947,986. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-12-06 WEINBERGER MARK A Director Grant or award · Deferred Share Units +241.02 $178.70 $43K 6,276.05
2022-12-06 Washington A. Eugene Director Grant or award · Deferred Share Units +350.74 $178.70 $63K 28,162.94
2022-12-06 HEWSON MARILLYN A Director Grant or award · Deferred Share Units +240.47 $178.70 $43K 6,152.49
2022-11-30 McEvoy Ashley EVP, WW Chair, MedTech Exercise or conversion +73,323 $72.54 $5.3M 115,135.95
2022-11-30 McEvoy Ashley EVP, WW Chair, MedTech Sale −1,400 $176.09 $247K 113,735.95
2022-11-30 McEvoy Ashley EVP, WW Chair, MedTech Sale −71,923 $175.46 $12.6M 41,812.95
2022-11-30 McEvoy Ashley EVP, WW Chair, MedTech Exercise or conversion · Employee Stock Options (Right to Buy) −73,323 0
2022-11-22 Taubert Jennifer L EVP, WW Chair, Pharmaceuticals Exercise or conversion +76,923 $72.54 $5.6M 203,379
2022-11-22 Taubert Jennifer L EVP, WW Chair, Pharmaceuticals Sale −76,923 $176.78 $13.6M 126,456
2022-11-22 Taubert Jennifer L EVP, WW Chair, Pharmaceuticals Exercise or conversion · Employee Stock Options (Right to Buy) −76,923 0
2022-11-18 Decker Robert J Controller, CAO Exercise or conversion +16,928 $90.44 $1.5M 32,401
2022-11-18 Decker Robert J Controller, CAO Sale −16,928 $175.00 $3.0M 15,473
2022-11-18 Decker Robert J Controller, CAO Exercise or conversion · Employee Stock Options (Right to Buy) −16,928 0
2022-11-09 Wengel Kathryn E EVP, Chief GSC Officer Exercise or conversion +16,410 $72.54 $1.2M 87,720.87
2022-11-09 Wengel Kathryn E EVP, Chief GSC Officer Sale −16,410 $173.42 $2.8M 71,310.87
2022-11-09 Wengel Kathryn E EVP, Chief GSC Officer Exercise or conversion · Employee Stock Options (Right to Buy) −16,410 0
2022-11-07 Mongon Thibaut Exec VP, WW Chair, Consumer Exercise or conversion +10,033 $115.67 $1.2M 50,166.27
2022-11-07 Mongon Thibaut Exec VP, WW Chair, Consumer Exercise or conversion +7,010 $101.87 $714K 57,176.27
2022-11-07 Mongon Thibaut Exec VP, WW Chair, Consumer Exercise or conversion · Employee Stock Options (Right to Buy) −7,010 $101.87 $714K 0
2022-11-07 Mongon Thibaut Exec VP, WW Chair, Consumer Exercise or conversion · Employee Stock Options (Right to Buy) −10,033 $115.67 $1.2M 0

Page 40 of 60 · 1,189 trades